1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66745755FB3FAD1540025887F0038FCF6
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/insights/6745755FB3FAD1540025887F0038FCF6!OpenDocument
18
19OpenDocument
2035.175.107.185
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB






Products & Services >> Best Practice Database >>Archived Research Alerts >>June 2022 Research

JUNE 2022 Research Alert

This month we added three new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies explore the current landscape for the Competitive Intelligence function. Together, the three documents act as a soup to nuts snapshot of the CI role in pharma right now. The first study examines operational models and roles and responsibilities; the second study explores staffing, activities, and budgeting. The last study reviews capabilities enhancement and technology advancement.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.


Download: Optimizing the Competitive Intelligence Function: Operating Model, Roles and Responsibilities (5724)

This study delivers benchmarks and insights around current approaches to the operating model, roles and responsibilities of the Competitive Intelligence function.


Download: Optimizing the Competitive Intelligence Function: Staffing, Activities and Budgeting (5725)

Best Practices, LLC undertook this research to deliver benchmarks and insights around staffing, activities, and budgeting of the Competitive Intelligence function.


Download: Optimizing the Competitive Intelligence Function: Building Capabilities and Technology Advancement (5726)

Best Practices, LLC conducted this benchmarking study to identify how leading pharmaceutical and biotechnology companies are maximizing the impact of their Competitive Intelligence function.